0001814554-25-000201.txt : 20251217 0001814554-25-000201.hdr.sgml : 20251217 20251217164833 ACCESSION NUMBER: 0001814554-25-000201 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering ITEM INFORMATION: Investment Company Act Section 3(c) ITEM INFORMATION: Section 3(c)(1) FILED AS OF DATE: 20251217 DATE AS OF CHANGE: 20251217 EFFECTIVENESS DATE: 20251217 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BIOMEDICAL VALUE FUND, L.P. CENTRAL INDEX KEY: 0001267460 ORGANIZATION NAME: EIN: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-425941 FILM NUMBER: 251579934 BUSINESS ADDRESS: STREET 1: 165 MASON STREET, 3RD FLOOR CITY: GREENWICH STATE: CT ZIP: 06830 BUSINESS PHONE: (203) 971-3307 MAIL ADDRESS: STREET 1: 165 MASON STREET, 3RD FLOOR CITY: GREENWICH STATE: CT ZIP: 06830 FORMER COMPANY: FORMER CONFORMED NAME: BIOMEDICAL VALUE FUND I DATE OF NAME CHANGE: 20050211 FORMER COMPANY: FORMER CONFORMED NAME: BIOMEDICAL VALUE FUND L P DATE OF NAME CHANGE: 20031017 D/A 1 primary_doc.xml X0708 D/A LIVE 0001267460 BIOMEDICAL VALUE FUND, L.P. 165 MASON STREET, 3RD FLOOR GREENWICH CT CONNECTICUT 06830 (203) 971-3300 DELAWARE BIOMEDICAL VALUE FUND BIOMEDICAL VALUE FUND I BIOMEDICAL VALUE FUND L P Limited Partnership true -- Great Point GP, LLC 165 MASON STREET, 3RD FLOOR GREENWICH CT CONNECTICUT 06830 Promoter General Partner of the Issuer. -- Great Point Partners, LLC 165 MASON STREET, 3RD FLOOR GREENWICH CT CONNECTICUT 06830 Promoter Manager of the Issuer. Jeffrey R. Jay 165 MASON STREET, 3RD FLOOR GREENWICH CT CONNECTICUT 06830 Executive Officer Senior Managing Member of the Manager and the General Partner of the Issuer. Pooled Investment Fund Hedge Fund false Decline to Disclose 06b 3C 3C.1 true 0001267460-24-000002 2011-09-30 true true false 0 Indefinite 623468953 Indefinite false 93 0 0 0 false BIOMEDICAL VALUE FUND, L.P. /s/ Jeffrey R. Jay, M.D. Jeffrey R. Jay, M.D. Senior Managing Member of the General Partner of the Issuer 2025-12-17